Background illustration for clinical trials search

Paid Clinical Trials Aurora

Discover 1,584 paid clinical trials in Aurora, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,584

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for

Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma,

Location: Aurora CO, Denver CO, Highlands Ranch CO, Greeley CO,

Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05256225

Phase3, Recruiting

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

for

Glioblastoma, Recurrent Glioblastoma, GBM

Location: Aurora CO, Salt Lake City UT, Phoenix AZ, Dallas TX,

Sponsor: CarThera

Sex: All

Age: 18+

Code: NCT05902169

Phase3, Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

for

Pulmonary Hypertension Due to Lung Disease (Disorder)

Location: Aurora CO, Denver CO, Scottsdale AZ, Phoenix AZ,

Sponsor: Liquidia Technologies, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07285655

Phase3, Recruiting

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

for

Advanced NRAS-Mutant Melanoma,

Location: Aurora CO, Los Angeles CA, San Francisco CA,

Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07584226

Phase1, Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

for

Recurrent Glioblastoma, IDH-Wildtype,

Location: Aurora CO, Oklahoma City OK, Phoenix AZ, Rochester MN,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05432804

Phase1, Phase2, Recruiting

Study of Placental Function in Healthy and Pathological Pregnancies

for

Pregnancy

Location: Aurora CO

Sponsor: University of Colorado, Denver

Sex: Female

Age: 18 - 45

Code: NCT02321007

Recruiting

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

for

Gastric Adenocarcinoma,

Location: Aurora CO, Albuquerque NM, Salt Lake City UT, Fargo ND,

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT07001748

Phase2, Phase3, Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

for

Muscle Invasive Bladder Urothelial Carcinoma,

Location: Aurora CO, Denver CO, Lone Tree CO, Highlands Ranch CO,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07097142

Phase3, Recruiting

Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease

for

Hyperlipidemia

Location: Aurora CO

Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT07334834

Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for

Gastrointestinal Neoplasms

Location: Aurora CO, Salt Lake City UT, Omaha NE,

Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase3, Recruiting

Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity

for

Post-acute Sequelae of SARS-CoV-2 Infection

Location: Aurora CO

Sponsor: University of Colorado, Denver

Sex: All

Age: 18+

Code: NCT05566483

Recruiting

Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial

for

Metastatic Bone Disease

Location: Aurora CO, Portland OR, Fort Wayne IN, Cincinnati OH

Sponsor: Michelle Ghert, MD

Sex: All

Age: 18+

Code: NCT06863129

Recruiting

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

for

Aortic Arch Aneurysm, Aortic Arch Dissection,

Location: Aurora CO, Plano TX, Austin TX, Los Angeles CA,

Sponsor: Artivion Inc.

Sex: All

Age: 18 - 70+

Code: NCT07089576

Recruiting

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

for

Metastatic Colorectal Adenocarcinoma,

Location: Aurora CO, Oklahoma City OK, Orange CA, Irvine CA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06102902

Phase1, Recruiting

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

for

Locally Advanced Adrenal Cortical Carcinoma,

Location: Aurora CO, Omaha NE, Bellevue NE, Oklahoma City OK,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12+

Code: NCT06900595

Phase2, Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for

Non-Small-Cell Lung Cancer,

Location: Aurora CO, Dallas TX, Fullerton CA, Orange CA,

Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase3, Recruiting

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for

Locally Advanced Cervical Adenocarcinoma,

Location: Aurora CO, Highlands Ranch CO, Albuquerque NM,

Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07061977

Phase3, Recruiting

Preventing Maternal Mood, Anxiety, and Trauma Symptoms After Cesarean Delivery

for

Anxiety in Pregnancy,

Location: Aurora CO

Sponsor: University of Colorado, Denver

Sex: Female

Age: 0+

Code: NCT06949813

Recruiting

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

for

Charcot-Marie-Tooth Disease, Type Ia (Disorder), HMSN

Location: Aurora CO, Maple Grove MN, Iowa City IA, Los Angeles CA,

Sponsor: University of Iowa

Sex: All

Age: 0+

Code: NCT01193088

Recruiting

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

for

Charcot Marie Tooth Disease

Location: Aurora CO, Minneapolis MN, Iowa City IA, Los Angeles CA,

Sponsor: Michael Shy

Sex: All

Age: 0+

Code: NCT01193075

Recruiting

Paid Clinical Trials Aurora

Filter results

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Interested in new trials?

Study of Placental Function in Healthy and Pathological Pregnancies

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacity

Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Trial

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer

Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Preventing Maternal Mood, Anxiety, and Trauma Symptoms After Cesarean Delivery

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others